RCMNY
RETA

Rubric Capital Management (New York)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Rubric Capital Management (New York)’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-138,556
Closed -$4.54M – 98
2022
Q1 		$4.54M Buy
+138,556
New +$4.54M 0.16% 57